This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197–204.
Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007; 109: 1322–1330.
Terasaki PI . Humoral theory of transplantation. Am J Transplant 2003; 3: 665–673.
Goodman RS, Taylor CJ, O’Rourke CM, Lynch A, Bradley JA, Key T . Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Transplantation 2006; 81: 1331–1336.
Colombo MB, Haworth SE, Poli F, Nocco A, Puglisi G, Innocente A et al. Luminex technology for anti-HLA antibody screening evaluation of performance and impact of laboratory routine. Cytometry B Clin Cytom 2007; 72B: 465–471.
Taylor PA, Ehrhardt MJ, Roforth MM, Swedin JM, Panoskaltsis-Mortari A, Serody JS et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007; 109: 1307–1315.
Maruta A, Fukawa H, Kanamori H, Harano H, Noguchi T, Kodama F et al. Donor-HLA-incompatible marrow transplantation with an anti-donor cytotoxic antibody in the serum of the patient. Bone Marrow Transplant 1991; 7: 397–400.
Narimatsu H, Wake A, Miura Y, Tanaka H, Matsumura T, Takagi S et al. Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion. Bone Marrow Transplant 2005; 36: 555–556.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kataoka, K., Yamamoto, G., Nannya, Y. et al. Successful engraftment following HLA-mismatched cord blood transplantation for patients with anti-HLA Abs. Bone Marrow Transplant 42, 129–130 (2008). https://doi.org/10.1038/bmt.2008.83
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.83
This article is cited by
-
The role of HLA antibodies in allogeneic SCT: is the ‘type-and-screen’ strategy necessary not only for blood type but also for HLA?
Bone Marrow Transplantation (2012)
-
Successful engraftment of a second transplant from unrelated cord blood identifying acceptable HLA Ag mismatches as treatment for primary graft failure possibly mediated by anti-HLA Abs after ‘mega-dose’ haploidentical PBSC transplantation
Bone Marrow Transplantation (2010)
-
Successful engraftment following umbilical cord blood transplantation for patients with HLA antibody with or without corresponding HLA in the transplanted cord blood
Bone Marrow Transplantation (2010)
-
Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection
Bone Marrow Transplantation (2010)